NO20060065L - Tabletter inneholdende enrofloksacin og smaks- og/eller aromastoffer - Google Patents

Tabletter inneholdende enrofloksacin og smaks- og/eller aromastoffer

Info

Publication number
NO20060065L
NO20060065L NO20060065A NO20060065A NO20060065L NO 20060065 L NO20060065 L NO 20060065L NO 20060065 A NO20060065 A NO 20060065A NO 20060065 A NO20060065 A NO 20060065A NO 20060065 L NO20060065 L NO 20060065L
Authority
NO
Norway
Prior art keywords
flavoring
tablets containing
containing enrofloxacin
agents
flavoring agents
Prior art date
Application number
NO20060065A
Other languages
English (en)
Other versions
NO338438B1 (no
Inventor
Venkata-Rangarao Kanikanti
Sabine Bongaerts
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33520986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060065(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20060065L publication Critical patent/NO20060065L/no
Publication of NO338438B1 publication Critical patent/NO338438B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Det er beskrevet tabletter for dyr, som inneholder enrofloksacin, samt smaks- og/eller aromastoffer.
NO20060065A 2003-06-26 2006-01-05 Tabletter inneholdende enrofloksacin og smaks- og/eller aromastoffer og fremgangsmåte for fremstilling derav. NO338438B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10328666A DE10328666A1 (de) 2003-06-26 2003-06-26 Tabletten enthaltend Geschmacks-und/oder Aromastoffe
PCT/EP2004/006370 WO2005000275A1 (de) 2003-06-26 2004-06-14 Tabletten enthaltend enrofloxacin und geschmack- und/oder aromastoffe

Publications (2)

Publication Number Publication Date
NO20060065L true NO20060065L (no) 2006-01-05
NO338438B1 NO338438B1 (no) 2016-08-15

Family

ID=33520986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060065A NO338438B1 (no) 2003-06-26 2006-01-05 Tabletter inneholdende enrofloksacin og smaks- og/eller aromastoffer og fremgangsmåte for fremstilling derav.

Country Status (30)

Country Link
US (1) US20090028936A1 (no)
EP (1) EP1641439B1 (no)
JP (2) JP5427341B2 (no)
KR (1) KR101119917B1 (no)
CN (1) CN100548280C (no)
AR (2) AR044704A1 (no)
AU (1) AU2004251003B2 (no)
BR (1) BRPI0411771B1 (no)
CA (1) CA2530639C (no)
CO (1) CO5650223A2 (no)
CR (1) CR8149A (no)
DE (2) DE10328666A1 (no)
DK (1) DK1641439T3 (no)
ES (1) ES2280973T3 (no)
GT (1) GT200400124A (no)
IL (1) IL172739A (no)
MX (1) MXPA05013875A (no)
MY (1) MY135825A (no)
NO (1) NO338438B1 (no)
NZ (1) NZ544365A (no)
PE (1) PE20050502A1 (no)
PL (1) PL1641439T3 (no)
PT (1) PT1641439E (no)
RU (1) RU2359699C2 (no)
SI (1) SI1641439T1 (no)
TW (1) TWI339124B (no)
UA (1) UA82529C2 (no)
UY (1) UY28380A1 (no)
WO (1) WO2005000275A1 (no)
ZA (1) ZA200510318B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100341510C (zh) * 2005-06-10 2007-10-10 冯莉萍 一种恩诺沙星微囊及制备方法
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
WO2010034853A1 (es) 2008-09-23 2010-04-01 Laboratorio Jaer, S.A. Utilización de exilitol o sus derivados para el enmascaramiento gustativo de quimioterapicos del grupo del ácido quinolon-o-naftiridoncarboxilico administrados en alimentos destinados a ganado porcino
RU2412704C1 (ru) * 2009-07-08 2011-02-27 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Великолукская государственная сельскохозяйственная академия" Способ лечения рожи свиней
MX347401B (es) * 2012-11-14 2017-04-18 Univ Mexico Nac Autonoma Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.
WO2014095845A1 (de) 2012-12-19 2014-06-26 Bayer Animal Health Gmbh Tabletten mit verbesserter akzeptanz und guter lagerstabilität
RU2554748C2 (ru) * 2013-07-09 2015-06-27 Общество с ограниченной ответственностью "БИОН" Средство для лечения энтеритов у животных
MX356443B (es) * 2013-12-11 2018-05-21 Univ Mexico Nac Autonoma Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
AU2345192A (en) * 1992-07-21 1994-02-14 Boots Company Plc, The Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
CR8149A (es) 2007-09-12
BRPI0411771A (pt) 2006-08-29
AR044704A1 (es) 2005-09-21
CO5650223A2 (es) 2006-06-30
MXPA05013875A (es) 2006-07-06
AU2004251003B2 (en) 2010-09-16
GT200400124A (es) 2005-03-03
RU2359699C2 (ru) 2009-06-27
DE502004002690D1 (de) 2007-03-08
JP5427341B2 (ja) 2014-02-26
PT1641439E (pt) 2007-04-30
IL172739A0 (en) 2006-04-10
JP2007506658A (ja) 2007-03-22
ES2280973T3 (es) 2007-09-16
UA82529C2 (uk) 2008-04-25
NZ544365A (en) 2009-10-30
EP1641439B1 (de) 2007-01-17
EP1641439A1 (de) 2006-04-05
HK1095515A1 (zh) 2007-05-11
KR20060063802A (ko) 2006-06-12
WO2005000275A1 (de) 2005-01-06
AR103567A2 (es) 2017-05-17
US20090028936A1 (en) 2009-01-29
NO338438B1 (no) 2016-08-15
DE10328666A1 (de) 2005-01-13
RU2006102033A (ru) 2006-06-10
MY135825A (en) 2008-07-31
CN100548280C (zh) 2009-10-14
DK1641439T3 (da) 2007-04-10
PE20050502A1 (es) 2005-08-18
TW200503759A (en) 2005-02-01
BRPI0411771B1 (pt) 2015-11-24
CA2530639C (en) 2012-01-03
SI1641439T1 (sl) 2007-06-30
TWI339124B (en) 2011-03-21
AU2004251003A1 (en) 2005-01-06
KR101119917B1 (ko) 2012-02-29
UY28380A1 (es) 2005-01-31
IL172739A (en) 2010-12-30
JP2012046533A (ja) 2012-03-08
CN1812769A (zh) 2006-08-02
ZA200510318B (en) 2007-04-25
PL1641439T3 (pl) 2007-08-31
CA2530639A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
DK1409459T3 (da) ECL mærker, som har forbedrede, non-specifikke bindingsegenskaber, fremgangsmåder til anvendelse deraf, og kits indeholdende samme.
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
NL1024261A1 (nl) Preparaten, die een indolinonverbinding bevatten.
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
AR103567A2 (es) Comprimidos que contienen saborizantes y/o aromatizantes
NO20053747D0 (no) Konfigurasjoner og fremgangsmater for diffraksjonsanalyse basert pa flytid for ultralyd.
BR0306273B1 (pt) meia concha de wafer, método de sua preparação e produto alimentìcio que a inclui.
NO20052487D0 (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
DK1511718T3 (da) N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer
NO20041432L (no) Sammensetninger som innbefatter COX-2 inhibitorer og aspirin.
ITMO20020337A1 (it) Dispositivo per anastomosi.
NO20013853D0 (no) Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
AP2005003242A0 (en) Broadspectrum 2-aminobenzothiazole sulfonamide HIVprotease inhibitors.
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
ITMI20031619A1 (it) Amplificatore di rilevamento perfezionato.
BR0308321A (pt) Inibidores da peptìdeo deformilase
WO2005001133A3 (en) Compositions and methods for high throughput construction and functional analysis of expression libraries
ITVI20020268A1 (it) Dispositivo paraspifferi, particolarmente per porte ed infissi similari.
BR0306008B1 (pt) método para descascar uma árvore, dispositivo utilizado para descascar uma árvore, e, sistema compreendendo o mesmo.
NL1020966A1 (nl) Houder voor een voorwerp, voorzien van samenwerkende gekruiste polarisatoren.
ES1052566Y (es) Jamonero.
ES1052024Y (es) Jamonero.
ITMI20031077A1 (it) Autocattura antisoffocamento silenziosa, per bovini.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ELANCO ANIMAL HEALTH GMBH, DE